3684-00-2 Usage
Uses
Used in Industrial and Consumer Products:
1-ISOTHIAZOL-5-YL-ETHANONE is used as a preservative in various applications for its ability to prevent the growth of bacteria, fungi, and other microorganisms. This ensures the longevity and quality of the products in which it is used.
Used in Paints and Coatings:
1-ISOTHIAZOL-5-YL-ETHANONE is used as a preservative in paints and coatings to protect against microbial contamination, which can cause spoilage and degradation of the product.
Used in Adhesives:
In the adhesives industry, 1-ISOTHIAZOL-5-YL-ETHANONE serves as a preservative to prevent microbial growth that could compromise the adhesive's performance and integrity.
Used in Personal Care Products:
1-ISOTHIAZOL-5-YL-ETHANONE is used as a preservative in personal care products to ensure their safety and efficacy by preventing the proliferation of harmful microorganisms that could cause infections or skin irritations.
Check Digit Verification of cas no
The CAS Registry Mumber 3684-00-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,6,8 and 4 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 3684-00:
(6*3)+(5*6)+(4*8)+(3*4)+(2*0)+(1*0)=92
92 % 10 = 2
So 3684-00-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H5NOS/c1-4(7)5-2-3-6-8-5/h2-3H,1H3
3684-00-2Relevant academic research and scientific papers
SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
-
Paragraph 00419-00420, (2021/04/01)
The invention provides substituted imidazole carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat a medical disorder, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.
CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME
-
Page/Page column 187-188, (2018/09/21)
The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.
